Market revenue in 2022 | USD 46.9 million |
Market revenue in 2030 | USD 84.8 million |
Growth rate | 7.7% (CAGR from 2022 to 2030) |
Largest segment | Evaporative dry eye syndrome |
Fastest growing segment | Evaporative Dry Eye Syndrome |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.52% in 2022. Horizon Databook has segmented the Argentina dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
According to World Bank statistics from 2018, Argentina's current health spending, including health services, accounts for 9.62% of the country's annual GDP. Argentina lacks proper healthcare coverage; over 36% of its population does not have any formal healthcare coverage and is dependent on the public healthcare system. However, its health expenditure is also 1.1% higher than the average of the Latin American region.
Increase in the number of government initiatives, coupled with the rising incidence of dry eye disease, is expected to drive the market over the forecast period. Moreover, environmental factors are adding to the increasing dry eye disease episodes in the region. For instance, increased air pollution from biomass burning is linked to a decline in tear film stability (TBUT), resulting in areas of ocular surface exposure, which could be the source of irritation.
Furthermore, since 1971, the National Institute of Social Services for Retirees and Pensioners (PAMI) has been providing free of cost healthcare to the geriatric population in Argentina. Since its inception, PAMI has conducted several programs aimed at improving the health of Argentina's senior citizens. The PAMI provides free healthcare to people aged 65 and older as well as resources such as support networks and immunization.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina dry eye syndrome treatment market , including forecasts for subscribers. This country databook contains high-level insights into Argentina dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account